Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-Injectable Cabotegravir Antiretroviral Salvage Strategy Options Trial

NCT06485154 is registered in ClinicalTrials.gov with University of Witwatersrand, South Africa as lead sponsor.

NCT NCT06485154
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06485154 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-Injectable Cabotegravir Antiretroviral Salvage Strategy Options Trial
Lead sponsor
University of Witwatersrand, South Africa
Phase
Phase 4
Overall status
Recruiting
Start date
June 1, 2024
Completion date
August 31, 2026
Enrollment
100 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hiv prevention